19 November 2017
News and Views
Links and Services
A meta-analysis in the latest Journal of Viral Hepatitis investigates interferon-alpha prevents the recurrence after curative treatment of hepatitis C virus-related hepatocellular carcinoma.
Various clinical studies have indicated that interferon-alpha treatment prevents the development
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors